Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Thermo Fisher Scientific's CEO, Marc N. Casper, exercised stock options and sold shares of common stock on March 11 and 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 11 and 12, 2024, Marc N. Casper, the Chairman and CEO of Thermo Fisher Scientific, exercised stock options to acquire 10,000 shares on each day at a price of $190.59 per share.
- Concurrently, Casper sold shares of Thermo Fisher Scientific common stock on the open market at prices ranging from approximately $590 to $600 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2023.
- Following these transactions, Casper directly owns 123,816.462 shares of Thermo Fisher Scientific common stock.
- Casper also indirectly owns 11,300 shares through the Alison Casper 2020 Irrevocable Trust, 43,608 shares through Floral Park Associates, Inc., and 5,000 shares through the MNC 2020 Irrevocable Trust.
- He also holds options to purchase 66,300 shares of common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions under a pre-existing plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation practices, including stock options and sales, are common across the pharmaceutical and life sciences industries.
- Companies like Danaher, Agilent, and PerkinElmer also utilize stock-based compensation for their executives.
- The use of Rule 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2023-11-10 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-03-11 | Date of stock option exercise and share sales |
| 2024-03-12 | Date of stock option exercise and share sales |
| 2024-03-13 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.